Evidence map›Paper›PMID 37790813›Full record

ArticleFrontiers in pharmacology2023

The influence of adjunctive traditional Chinese medicine therapy on survival in primary liver cancer: a real-world study based on electronic medical records.

Ruixia Zhao, Linlin Wang, Yibing Liu, Mingyi Shao, Wei Yang, Yu Fu, Qilong Gao, Jun'an Feng, Yunfei Xing, Xinghua Xiang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Natural Compounds for Preventing Age-Related Diseases and Cancers.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ruixia ZhaoThe First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Linlin WangThe First Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
Yibing LiuThe First Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
Mingyi ShaoThe First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Wei YangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Yu FuThe First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Qilong GaoDepartment of Integrated Traditional Chinese Medicine and Modern Medicine, Henan Cancer Hospital, Zhengzhou, Henan, China.
Jun'an FengDepartment of Digestive, People's Hospital of Zhengzhou, Zhengzhou, Henan, China.
Yunfei XingThe First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Xinghua XiangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
First Affiliated Hospital of Henan University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNHenan University of Traditional Chinese Medicine · CNHenan Cancer Hospital · CNZhengzhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

electronic medical recordprimary liver cancerreal-world studysurvival analysistraditional Chinese medicine

Identifiers

PMID37790813
PMCPMC10544965
OpenAlexW4386864084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.